Prestige Consumer Healthcare PBH
NYSE PBH
$51.31 +0.79 (+1.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015)

Prestige Consumer Healthcare (PBH) posted quarterly Amortizatization of Intangibles of $750000.0 for Q1 2015, up 154.24% year-over-year from $295000.0 in Q1 2014, and up 15.56% quarter-over-quarter from $649000.0 in Q4 2014.

Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015) Analysis & Trends

Prestige Consumer Healthcare's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $750000.0 for Q1 2015.

  • In Q1 2015, Amortizatization of Intangibles rose 154.24% year-over-year to $750000.0; the TTM figure through Mar 2015 stood at $2.1 million (down 38.83% YoY), while the FY2015 annual figure was $2.1 million, down 38.83% from the prior year.
  • Amortizatization of Intangibles for Q1 2015 stood at $750000.0, up from $649000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $3.1 million in Q4 2012, with the low at $144000.0 in Q2 2014.
  • The 5-year median for Amortizatization of Intangibles is $404000.0 (2012), against an average of $669411.8.
  • The sharpest annual moves came in 2012 and 2014: Amortizatization of Intangibles surged 1244.98% in 2012, then sank 71.99% in 2014.
  • Prestige Consumer Healthcare's Amortizatization of Intangibles stood at $229000.0 in 2011, then soared by 1244.98% to $3.1 million in 2012, then retreated by 24.77% to $2.3 million in 2013, then tumbled by 71.99% to $649000.0 in 2014, then increased by 15.56% to $750000.0 in 2015.
  • Business Quant data shows PBH's Amortizatization of Intangibles at $750000.0 in Q1 2015, $649000.0 in Q4 2014, and $543000.0 in Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 900,000.00
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Prestige Consumer Healthcare 2.46 Bn 2.39 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2015 750,000.00
Mar 31, 2015 750,000.00
Dec 31, 2014 649,000.00
Dec 31, 2014 649,000.00
Sep 30, 2014 543,000.00
Sep 30, 2014 543,000.00
Jun 30, 2014 144,000.00
Jun 30, 2014 144,000.00
Mar 31, 2014 295,000.00
Mar 31, 2014 295,000.00
Dec 31, 2013 2.32 Mn
Dec 31, 2013 2.32 Mn
Sep 30, 2013 453,000.00
Sep 30, 2013 453,000.00
Jun 30, 2013 345,000.00
Jun 30, 2013 345,000.00
Mar 31, 2013 740,000.00
Mar 31, 2013 740,000.00
Dec 31, 2012 3.08 Mn
Dec 31, 2012 3.08 Mn